SETD2 was found to be the most significantly recurrently mutated gene (MutSigCV P value=2.5 × 10−15 and a false discovery rate=4.8 × 10−11), observed in 86% (13/15) of EATL-II tumours with 20 distinctive mutations. The gene discussed is SETD2; the disease is neoplasm.